MAR 27   

Audited Final Results for the Year Ended 31 December 2024


MAR 25   

Voluntary Operational Update - Submission of Senstend New Drug Application to the National Medical Products Administration in China


MAR 17   

Date of Board Meeting


MAR 03   

Monthly Return of Equity Issuer on Movements in Securities


Feb 04   

Estimated Results for the Year Ended 31 December 2024


FEB 03   

Monthly Return of Equity Issuer on Movements in Securities


JAN 27   

Change of Branch Share Registrar and Transfer Office in Hong Kong


JAN 03   

Monthly Return of Equity Issuer on Movements in Securities